OTC · Drug Manufacturers - Specialty & Generic

CBD Global Sciences Inc. (CBDNF) Stock

$0.04 -2.67% OTC: CBDNF Healthcare

CBD Global Sciences Inc. operates within the cannabidiol (CBD) sector, handling the cultivation, processing, and manufacturing of CBD products.

Valuation

MetricValue
Price$0.04
Market Cap$2.07M
P/E Ratio-0.20
P/B Ratio-0.67
P/S Ratio9.45
EPS (TTM)$-0.15
52-Week High$0.12
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE116.17%
ROA-276.92%
ROCE—
Gross Margin24.56%
Operating Margin—
Net Margin—
Debt/Equity-1.41
Current Ratio0.16

Annual Financials (USD)

Metric201920202021
Revenue$2.0M$0$0
Operating Profit$-2.0M$-3.0M$-3.0M
Net Profit$-9.0M$-9.0M$-5.0M
EPS$-0.53$-0.28$-0.15
Op Margin-102.2%-868.5%-1641.2%

Balance Sheet (USD)

Metric201920202021
Total Assets$6.0M$0$2.0M
Total Liabilities$7.0M$9.0M$4.0M
Cash$0$0$0
Borrowings$5.0M$5.0M$2.0M

Latest News

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Tech Earnings MT Newswires · Jul 30, 2026 Heartland Express: Q2 Earnings Snapshot Associated Press · Jul 30, 2026 Kite Realty Group Trust Q2 Core FFO Rises, Revenue Falls; Reaffirms 2026 Guidance MT Newswires · Jul 30, 2026 Terex Q2 Adjusted Earnings Fall, Net sales Rise; Fiscal 2026 Adjusted EPS, Revenue Outlook Boosted MT Newswires · Jul 30, 2026 Texas woman pleads guilty to smuggling sedated migrant children USA TODAY · Jul 30, 2026

Cash Flow (USD)

Metric201920202021
Operating Cash Flow$-2.0M$-1.0M$-1.0M
Investing Cash Flow$0$0$0
Financing Cash Flow$2.0M$1.0M$1.0M
Net Cash Flow$0$0$0
Free Cash Flow$-2.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.85
FCF Yield-72.36%
Quick Ratio0.06
Interest Coverage-5.08
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACNNFAusCann Group Holdings Ltd $0.00 — -1.63 $1.67M 0.00%
CANBCan B Corp. $0.02 +16.18% -0.11 $1.49M 0.00%
CIMVFPideka Group Inc. $0.01 +0.00% -1.16 $2.51M 0.00%
CPYTCarePayment Technologies, Inc. $0.00 — 0.00 $1667 0.00%
EEVVFEve & Co Incorporated $0.08 +0.00% -0.29 $2.86M 0.00%

About CBD Global Sciences Inc.

CBD Global Sciences Inc. operates within the cannabidiol (CBD) sector, handling the cultivation, processing, and manufacturing of CBD products. Its offerings include biomass, various CBD oils, and other CBD-based items, which are marketed under the Aethics, CannaOil, and Strasburg Pharms brands. Founded in 2018, the company's main offices are located in Lakewood, Colorado.

CBD Global Sciences Inc. is headquartered in US.

CBD Global Sciences Inc. (CBDNF) stock trades at $0.04 with a market capitalization of $2.07M. The stock is valued at a price-to-earnings (P/E) ratio of -0.20, price-to-book of -0.67, price-to-sales of 9.45. Over the past 52 weeks the stock has ranged between $0.02 and $0.12, and currently trades 66.7% below its 52-week high.

On profitability, CBD Global Sciences Inc. generates a return on equity (ROE) of 116.17% — well above the market average, a sign of a high-quality business.

Official website: www.cbdglobalsciences.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides